AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34620087 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracranial pressure (ICP) measurements at baseline, 12 months, and 24 months
Number of subjects: 66
Study 34620087 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracranial pressure (ICP) measurements at 12 months
Number of subjects: 66
Study 34620087 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracranial pressure (ICP) measurements at 12 and 24 months
Number of subjects: 66
Study 34620087 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracranial pressure (ICP) measurements
Number of subjects: 66
Study 32808036 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 34
Study 32808036 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 34
Study 32808036 — intervention group
Group type: EXPERIMENTAL
Intervention: Never-treated
Number of subjects: 34
Study 32808036 — intervention group
Group type: COMPARATOR
Intervention: Healthy control
Number of subjects: 34
Study 32808036 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine vs Risperidone
Number of subjects: 34
Study 36459413 — intervention group
Group type: EXPERIMENTAL
Intervention: HARK
Number of subjects: 40
Study 36459413 — intervention group
Group type: COMPARATOR
Intervention: HAJUS
Number of subjects: 40
Study 36459413 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HARK and HAJUS
Number of subjects: 40
Study 32706659 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and PA module
Number of subjects: 619
Study 32706659 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet module
Number of subjects: 619
Study 32706659 — intervention group
Group type: EXPERIMENTAL
Intervention: No module
Number of subjects: 619
Study 32706659 — intervention group
Group type: EXPERIMENTAL
Intervention: PA module only
Number of subjects: 619
Study 32706659 — intervention group
Group type: COMPARATOR
Intervention: Strong advice to follow diet module
Number of subjects: 619
Study 35395758 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 521
Study 35395758 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) with thorough information
Number of subjects: 521
Study 35395758 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) with brain circuitry-based causal explanation
Number of subjects: 521
Study 32897905 — intervention group
Group type: EXPERIMENTAL
Intervention: Low systolic blood pressure (SBP <120 mmHg)
Number of subjects: 11083
Study 32897905 — intervention group
Group type: EXPERIMENTAL
Intervention: Low diastolic blood pressure (DBP <70 mmHg)
Number of subjects: 11083
Study 32897905 — intervention group
Group type: COMPARATOR
Intervention: Normal SBP (≥120 mmHg)
Number of subjects: 11083
Study 32897905 — intervention group
Group type: COMPARATOR
Intervention: Normal DBP (≥70 mmHg)
Number of subjects: 11083
Study 36276341 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality technology combined with conventional rehabilitation strategies
Number of subjects: 44
Study 36276341 — intervention group
Group type: COMPARATOR
Intervention: Conventional/routine clinical rehabilitation training
Number of subjects: 44
Study 36334390 — intervention group
Group type: EXPERIMENTAL
Intervention: RYN plus standard care
Number of subjects: 2830
Study 35611516 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter mitral valve repair (TMVR) with the MitraClip device
Number of subjects: 307
Study 35611516 — intervention group
Group type: COMPARATOR
Intervention: Guideline-directed medical therapy (GDMT)
Number of subjects: 307
Study 32141723 — intervention group
Group type: EXPERIMENTAL
Intervention: OLZ/SAM
Number of subjects: 401
Study 32141723 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 401
Study 32141723 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 401
Study 35091135 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediabetes Clinical Decision Support (CDS) tool
Number of subjects: 34
Study 35091135 — intervention group
Group type: COMPARATOR
Intervention: No access to Pre-D CDS tool (Control)
Number of subjects: 34
Study 34717700 — intervention group
Group type: EXPERIMENTAL
Intervention: LOV group (tidal volume of 3‐4 ml/kg, respiratory rate of 10‐12 bpm, PEEP of 5‐8 cmH2O, FiO2 30%)
Number of subjects: 413
Study 34717700 — intervention group
Group type: EXPERIMENTAL
Intervention: HOV group (same ventilation parameters as LOV group, FiO2 80%)
Number of subjects: 413
Study 34717700 — intervention group
Group type: COMPARATOR
Intervention: NoV group (no mechanical ventilation during CPB)
Number of subjects: 413
Study 32901066 — intervention group
Group type: EXPERIMENTAL
Intervention: 11 SNPs associated with 28 outcomes (Bonferroni corrected P value < 4.63·10‐6)
Number of subjects: 422417
Study 32901066 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple SNP MR analysis
Number of subjects: 422417
Study 35660801 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 217
Study 35660801 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study 32926502 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MED)
Number of subjects: 12
Study 32926502 — intervention group
Group type: COMPARATOR
Intervention: High-fibre vegetarian diet (HFV)
Number of subjects: 12
Study 32408153 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie restriction (daily or intermittently)
Number of subjects: 90
Study 32408153 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (TRF) diet
Number of subjects: 90
Study 32408153 — intervention group
Group type: COMPARATOR
Intervention: Calorie restriction and time-restricted feeding
Number of subjects: 90
Study 34788110 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-line ART without resistance
Number of subjects: 214
Study 34788110 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative genotypic susceptibility score (cGSS)
Number of subjects: 214
Study 35636225 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive swallowing intervention for 4 weeks
Number of subjects: 60
Study 35636225 — intervention group
Group type: COMPARATOR
Intervention: Control group (swallowing care only)
Number of subjects: 60
Study 32712560 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimavanserin 34 mg once daily
Number of subjects: 459
Study 34611042 — intervention group
Group type: COMPARATOR
Intervention: Conventional antibiotic treatment
Number of subjects: 400
Study 34611042 — intervention group
Group type: COMPARATOR
Intervention: Partial oral antibiotic treatment
Number of subjects: 400
Study 32861652 — intervention group
Group type: EXPERIMENTAL
Intervention: TMVr for MR-dominant (MD) patients
Number of subjects: 1016
Study 32861652 — intervention group
Group type: EXPERIMENTAL
Intervention: TMVr for MR-LV-co-dominant (MLCD) patients
Number of subjects: 1016
Study 32861652 — intervention group
Group type: EXPERIMENTAL
Intervention: TMVr for LV-dominant (LD) patients
Number of subjects: 1016
Study 32861652 — intervention group
Group type: EXPERIMENTAL
Intervention: TMVr for all groups
Number of subjects: 1016
Study 34919834 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine 25 mg/day (n=94)
Number of subjects: 400
Study 34919834 — intervention group
Group type: EXPERIMENTAL
Intervention: Agomelatine 10 mg/day (n=102)
Number of subjects: 400
Study 34919834 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 10-20 mg/day (n=99)
Number of subjects: 400
Study 34919834 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=101)
Number of subjects: 400
Study 33435869 — intervention group
Group type: EXPERIMENTAL
Intervention: FLS‐CARE (coordinated care programme)
Number of subjects: 1216
Study 33435869 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1216
Study 33393602 — intervention group
Group type: EXPERIMENTAL
Intervention: Numbee injection (needleless intraligamentary local anesthesia)
Number of subjects: 15
Study 33393602 — intervention group
Group type: COMPARATOR
Intervention: Traditional inferior alveolar nerve block (IANB)
Number of subjects: 15
Study 34716214 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 14671
Study 34716214 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14671
Study 33576107 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel (PZQ) treatment
Number of subjects: 400
Study 33576107 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time PCR screening
Number of subjects: 400
Study 32301744 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring interventions for the management of HDP
Number of subjects: 20
Study 35995946 — intervention group
Group type: EXPERIMENTAL
Intervention: VR intervention to experience the environmental impact of food behavior
Number of subjects: 123
Study 35995946 — intervention group
Group type: EXPERIMENTAL
Intervention: VR intervention
Number of subjects: 123
Study 35995946 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 123
Study 35995946 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation of normative feedback
Number of subjects: 123
Study 35995946 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation of geographical framing
Number of subjects: 123
Study 34593045 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin
Number of subjects: 18
Study 34593045 — intervention group
Group type: COMPARATOR
Intervention: Placebo (intranasal saline)
Number of subjects: 18
Study 32873262 — intervention group
Group type: EXPERIMENTAL
Intervention: GlobalConsent
Number of subjects: 400
Study 32873262 — intervention group
Group type: COMPARATOR
Intervention: Health-education attention control
Number of subjects: 400
Study 35260472 — intervention group
Group type: EXPERIMENTAL
Intervention: Bi-level Positive Airway Pressure (BPAP)
Number of subjects: 186
Study 35260472 — intervention group
Group type: COMPARATOR
Intervention: Nasal CPAP
Number of subjects: 186
Study 32756485 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD knowledge improvement program (two-day duration)
Number of subjects: 100
Study 32756485 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 100
Study 32756485 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial group participation
Number of subjects: 100
Study 32756485 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher qualification
Number of subjects: 100
Study 35132875 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype-guided P2Y12 inhibitor selection
Number of subjects: 3883
Study 35132875 — intervention group
Group type: COMPARATOR
Intervention: Conventional P2Y12 inhibitor selection
Number of subjects: 3883
Study 33615379 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh medium on D6 (n=603)
Number of subjects: 298
Study 33615379 — intervention group
Group type: COMPARATOR
Intervention: Continuous medium from D3 to D7 (n=620)
Number of subjects: 298
Study 33615379 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh medium on D6 (women ≥40 years old)
Number of subjects: 298
Study 33615379 — intervention group
Group type: COMPARATOR
Intervention: Continuous medium (women ≥40 years old)
Number of subjects: 298
Study 33615379 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall (all women)
Number of subjects: 298
Study 33563017 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasugrel 3.75 mg/day
Number of subjects: 3747
Study 33563017 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel 75 mg/day
Number of subjects: 3747
Study 35695197 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaming therapy
Number of subjects: 167
Study 35695197 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaming therapy with additional telerehabilitation
Number of subjects: 167
Study 35695197 — intervention group
Group type: EXPERIMENTAL
Intervention: Constraint‐Induced Movement therapy
Number of subjects: 167
Study 35695197 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional rehabilitation
Number of subjects: 167
Study 35695197 — intervention group
Group type: COMPARATOR
Intervention: All interventions
Number of subjects: 167
Study 34083234 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential androgen receptor signaling inhibitors (abiraterone and enzalutamide)
Number of subjects: 202
Study 33022096 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 157
Study 33022096 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 157
Study 33470732 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (30 min three to five times/week)
Number of subjects: 75
Study 33470732 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric handgrip training (five times weekly)
Number of subjects: 75
Study 33470732 — intervention group
Group type: COMPARATOR
Intervention: Sham-handgrip training (five times weekly)
Number of subjects: 75
Study 32864734 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 19
Study 32864734 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 36339427 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoporosis (OP)
Number of subjects: 0
Study 33196410 — intervention group
Group type: EXPERIMENTAL
Intervention: Young SMILES intervention group
Number of subjects: 40
Study 33196410 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual control group
Number of subjects: 40
Study 36353346 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypogastric arterial ligation (HAL) before hysterectomy
Number of subjects: 70
Study 33392969 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-session brief intervention (BI)
Number of subjects: 0
Study 33392969 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-session combined intervention (CoI)
Number of subjects: 0
Study 33392969 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 0
Study 35510164 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational and telemonitoring program
Number of subjects: 15
Study 34901997 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 convalescent plasma (CCP), approximately 250 mL
Number of subjects: 941
Study 34901997 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline), equivalent volume to CCP
Number of subjects: 941
Study 34531351 — intervention group
Group type: EXPERIMENTAL
Intervention: DBBM + liquid PRF (test)
Number of subjects: 7
Study 34531351 — intervention group
Group type: COMPARATOR
Intervention: DBBM alone (control)
Number of subjects: 7
Study 32467354 — intervention group
Group type: EXPERIMENTAL
Intervention: Engaging Men through Accountable Practice (EMAP)
Number of subjects: 1387
Study 32467354 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1387
Study 36172675 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (2gm/day)
Number of subjects: 34
Study 36172675 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 34
Study 35112380 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted staff training programme
Number of subjects: 932
Study 35112380 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 932
Study 34436846 — intervention group
Group type: EXPERIMENTAL
Intervention: 6.2% carbohydrate solution
Number of subjects: 11
Study 34436846 — intervention group
Group type: COMPARATOR
Intervention: Water placebo
Number of subjects: 11
Study 36196738 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) training consisting of six sessions
Number of subjects: 63
Study 36196738 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 63
Study 33029896 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric-powered ionic toothbrush
Number of subjects: 30
Study 33029896 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 30
Study 36149841 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray (56 or 84 mg) plus a newly initiated oral antidepressant
Number of subjects: 928
Study 32772861 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to clinicians' visit notes
Number of subjects: 0
Study 32772861 — intervention group
Group type: COMPARATOR
Intervention: Placebo studies
Number of subjects: 0
Study 32772861 — intervention group
Group type: COMPARATOR
Intervention: Survey data on patient and clinician experiences
Number of subjects: 0
Study 32086791 — intervention group
Group type: EXPERIMENTAL
Intervention: Naldemedine 0.2 mg once daily
Number of subjects: 344
Study 32086791 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 344
Study 35418506 — intervention group
Group type: EXPERIMENTAL
Intervention: 75% e‐cigarettes, high visibility
Number of subjects: 1034
Study 35418506 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% e‐cigarettes, high visibility
Number of subjects: 1034
Study 35418506 — intervention group
Group type: EXPERIMENTAL
Intervention: 75% e‐cigarettes, low visibility
Number of subjects: 1034
Study 35418506 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% e‐cigarettes, low visibility
Number of subjects: 1034
Study 35418506 — intervention group
Group type: EXPERIMENTAL
Intervention: High visibility e‐cigarette retail displays
Number of subjects: 1034
Study 35418506 — intervention group
Group type: EXPERIMENTAL
Intervention: Proportion of e‐cigarette images displayed
Number of subjects: 1034
Study 33459082 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized neurocognitive testing (CNT) administered after maximal physical exertion (MPE) at recovery intervals of Immediate, 10-minutes, and 20-minutes
Number of subjects: 30
Study 33459082 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized neurocognitive testing (CNT) administered after maximal physical exertion (MPE) at a 20-minute recovery interval
Number of subjects: 30
Study 33459082 — intervention group
Group type: COMPARATOR
Intervention: Control trial (no MPE)
Number of subjects: 30
Study 32569395 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesolv 10
Number of subjects: 83
Study 32569395 — intervention group
Group type: COMPARATOR
Intervention: Rhinocort® Aqua
Number of subjects: 83
Study 32569395 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 33776428 — intervention group
Group type: EXPERIMENTAL
Intervention: Aclidinium
Number of subjects: 3589
Study 35690254 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Tunnel (ST) MPFL reconstruction
Number of subjects: 90
Study 35690254 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-Tunnel (DT) MPFL reconstruction
Number of subjects: 90
Study 33894370 — intervention group
Group type: COMPARATOR
Intervention: Topical acyclovir therapy (AVT)
Number of subjects: 45
Study 33894370 — intervention group
Group type: COMPARATOR
Intervention: Photodynamic therapy (PDT)
Number of subjects: 45
Study 33894370 — intervention group
Group type: EXPERIMENTAL
Intervention: AVT + adjunctive PDT
Number of subjects: 45
Study 34234028 — intervention group
Group type: EXPERIMENTAL
Intervention: Health language training based on mothers' reproductive life narratives
Number of subjects: 0
Study 36327379 — intervention group
Group type: EXPERIMENTAL
Intervention: NOURISH‐T+ (Nourishing Our Understanding of Role modeling to Improve Support and Health for Healthy Transitions)
Number of subjects: 0
Study 36327379 — intervention group
Group type: COMPARATOR
Intervention: Brief NOURISH‐T (Enhanced Usual Care/EUC)
Number of subjects: 0
Study 33076707 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper Cervical Translatoric Mobilization (UCTM)
Number of subjects: 78
Study 33076707 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitory Suboccipital Technique (IST)
Number of subjects: 78
Study 33076707 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 78
Study 32527692 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 1382
Study 32527692 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1382
Study 35030333 — intervention group
Group type: EXPERIMENTAL
Intervention: Erdafitinib 8 mg/day UpT regimen
Number of subjects: 101
Study 34759278 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban setting
Number of subjects: 37
Study 34759278 — intervention group
Group type: COMPARATOR
Intervention: Rural setting
Number of subjects: 37
Study 34759278 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor microenvironments
Number of subjects: 37
Study 34759278 — intervention group
Group type: COMPARATOR
Intervention: Outdoor environments
Number of subjects: 37
Study 34759278 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor environments
Number of subjects: 37
Study 34759278 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal air sensor
Number of subjects: 37
Study 34759278 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin sensor
Number of subjects: 37
Study 35843287 — intervention group
Group type: COMPARATOR
Intervention: CF only for 18 hours before CE and simethicone 200mg in 150 ml water immediately prior to CE
Number of subjects: 229
Study 35843287 — intervention group
Group type: EXPERIMENTAL
Intervention: CF only + 2L of polyethylene glycol (PEG) 12 hours prior
Number of subjects: 229
Study 35843287 — intervention group
Group type: EXPERIMENTAL
Intervention: CF only + 1L PEG + sodium ascorbate 3 hours prior
Number of subjects: 229
Study 33508023 — intervention group
Group type: EXPERIMENTAL
Intervention: E. coli O157:H7 related diarrhea
Number of subjects: 378
Study 33508023 — intervention group
Group type: EXPERIMENTAL
Intervention: Rural residence
Number of subjects: 378
Study 33508023 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of undercooked meat
Number of subjects: 378
Study 33508023 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of raw vegetables and/or fruit juice
Number of subjects: 378
Study 33508023 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of bloody diarrhea
Number of subjects: 378
Study 33508023 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of under-five children in a household
Number of subjects: 378
Study 33508023 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of person with diarrhea in a household
Number of subjects: 378
Study 33508023 — intervention group
Group type: EXPERIMENTAL
Intervention: Owning domestic animal
Number of subjects: 378
Study 33508023 — intervention group
Group type: EXPERIMENTAL
Intervention: Uneducated mother
Number of subjects: 378